Comment From ASCO President Douglas W. Blayney, MD, On The FDA's Rule To Expand Patient Access To Investigational Drugs

Main Category: Cancer / Oncology
Also Included In: Clinical Trials / Drug Trials;  Regulatory Affairs / Drug Approvals
Article Date: 17 Aug 2009 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (1 votes)

Healthcare Prof:not yet rated


"ASCO is pleased that the FDA has issued new rules that strike a balance between meeting the immediate needs of seriously ill cancer patients today, while safeguarding the clinical trials system so it can develop new drugs to treat cancer patients in the future.

The new rules will make it clearer for doctors and patients to access experimental drugs when other treatment options have been exhausted and clinical trials are not available.

ASCO will be developing tools to ensure that oncologists understand the new rules and can help their patients benefit."

Source
ASCO

Article adapted by Medical News Today from original press release.
Visit our cancer / oncology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
ASCO. "Comment From ASCO President Douglas W. Blayney, MD, On The FDA's Rule To Expand Patient Access To Investigational Drugs." Medical News Today. MediLexicon, Intl., 17 Aug. 2009. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/160853.php>

APA
ASCO. (2009, August 17). "Comment From ASCO President Douglas W. Blayney, MD, On The FDA's Rule To Expand Patient Access To Investigational Drugs." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/160853.php.

Please note: If no author information is provided, the source is cited instead.


Cancer / Oncology

What is Cancer?

Cancer is a class of diseases characterized by out-of-control cell growth. There are over 100 different types of cancer, and each is classified by the type of cell that is initially affected. Read more...

Most Popular Articles



Follow Our Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cancer / Oncology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »